Concepedia

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, Mark Dolev, Shay Menascu, David Magalashvili, Shlomo Flechter, Uri Givon, Diana Guber,

Journal of Neuroimmunology · 2021 · 79 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.5K citations · Full text

, , +17

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text

, , +10

New Multiple Sclerosis Phenotypic Classification

Fred Lublin · European Neurology · 2014 · 4.3K citations

, , +8

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan, Noam Barda, Eldad Kepten et al. · New England Journal of Medicine · 2021 · 2.8K citations · Full text

, , +17

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

, , +16